# TerSera Therapeutics LLC – FDA Inspection, Oct 5, 2023

Source: https://www.keypedia.com/records/fda_inspections/tersera-therapeutics-llc/6b2b0f05-0155-4206-90ca-9bcc3dbb262a
Source feed: FDA_Inspections

> FDA inspection 1221531 of TerSera Therapeutics LLC, October 05, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221531
- Company Name: TerSera Therapeutics LLC
- Inspection Date: 2023-10-05
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Company Rep](https://www.keypedia.com/people/colleen-e-burke/e013131b-6c14-4a60-b3ab-d8759d38624b)
- [Company Rep](https://www.keypedia.com/people/jeanne-j-thai/f7b057a4-ab4c-43de-a448-384ff9f8598f)
- [Company Rep](https://www.keypedia.com/people/yuanyuan-li/2043568b-a6ac-4f49-8018-c2c8edda8ac5)

Company: https://www.keypedia.com/companies/tersera-therapeutics-llc/80a529eb-5d68-4549-8efb-d7cf94fa65d4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c